Reversible Inhibitors of Monoamine Oxidase (RIMAs)

RIMAs are a new generation of MAOIs developed specifically to be safer than their older counterparts. Unlike the older MAOIs, RIMAs only inhibit the enzyme, monoamine oxidase type A, not monoamine oxidase type B, as do the older MAOIs.

The only currently available RIMA in Canada is moclobemide (Manerix).